RIVABAZUMAB PEGOL
UNII T3V24FDA87

Substance Identification & Data

This profile provides standardized clinical and technical data for Rivabazumab Pegol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) T3V24FDA87.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1613506-32-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

T3V24FDA87

CAS Registry Number

1613506-32-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RIVABAZUMAB PEGOL

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C152236

National Cancer Institute reference terminology for clinical and research data.

INN ID

10144

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rivabazumab Pegol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RIVABAZUMAB PEGOL

Common Names & Synonyms

IMMUNOGLOBULIN FAB' G1-KAPPA PEGYLATED, ANTI-PSEUDOMONAS AERUGINOSA TYPE III SECRETION SYSTEM (TTSS)PCRV PROTEIN, PEGYLATED HUMANIZED MONOCLONAL ANTIBODY

KB001-A

KB001-A (AN ANTI-PCRV PEGYLATED MONOCLONAL ANTIBODY FRAGMENT TO THE TYPE III SECRETION SYSTEM OF PSEUDOMONAS AERUGINOSA)

RIVABAZUMAB PEGOL [INN]

RIVABAZUMAB PEGOL [WHO-DD]